MENU
Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 23, 2023

Weekly Trading Analysis - Top Losers ($APLS, $VIR, $GNLX, and More)

AI Robots: Trading in Every Style - Analyzing the Market Shifts

Artificial Intelligence (AI) is a technology that has undoubtedly transformed the world. As its applications continue to expand across multiple sectors, it has also begun to make waves in the financial industry. The advent of AI robots has been particularly prominent in the world of stock trading, demonstrating their ability to trade in every style and presenting a new frontier for the capital markets.

In a recent week, AI trading robots showed their flexibility and adaptability by making market moves based on a wide variety of investment styles. The group of signals, from the more conservative to the speculative, reflects the diverse strategies that AI robots can employ.

In particular, the stocks of $APLS, $VIR, $GNLX, $FNGR, $RCLFU, $MASI, $VIGL, $SFWL, $LESL, $BTDR, that found themselves on the top losers list in the past week, provided some interesting insights.

While the stocks exhibited different market behaviors, what they have in common is that they were all traded by AI robots. These algorithms analyzed vast amounts of data in real time, picked up market trends, made predictions, and executed trades based on their programming.

In the case of $APLS and $VIR, the AI robots demonstrated an ability to participate in the biotech sector, which is known for its complexity and high-risk, high-reward nature. The robots were able to engage in this sector by analyzing countless research reports, clinical trial data, and market trends to make informed decisions.

On the other hand, the AI robots traded $FNGR and $RCLFU, which belong to the technology and entertainment sectors respectively. Here, the robots made use of sophisticated sentiment analysis, drawing on social media feeds, news articles, and company reports to gauge market sentiment and make trades accordingly.

Further, the AI robots also traded $MASI, $VIGL, $SFWL, $LESL, $BTDR, stocks that fall into a range of other sectors, from medical technology to security and protection services, leisure products, and software applications. The variety of these sectors demonstrates the wide-ranging capabilities of AI robots to analyze and engage in diverse market sectors.

The ability of AI robots to trade stocks in every style has interesting implications for the future of trading. They can work 24/7, process more information than a human trader, and execute trades in a matter of milliseconds. In addition, their ability to engage in diverse market sectors and their adaptability to various trading styles demonstrate their potential to play a more significant role in the future of trading.

Related Ticker: APLS, VIR, GNLX, FNGR, RCLFU, MASI, VIGL, SFWL, LESL, BTDR

APLS sees MACD Histogram crosses below signal line

APLS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 11, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for APLS entered a downward trend on March 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where APLS's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APLS advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

APLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.755) is normal, around the industry mean (11.936). P/E Ratio (0.000) is within average values for comparable stocks, (64.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.794). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (3.973) is also within normal values, averaging (235.669).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. APLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.45B. The market cap for tickers in the group ranges from 151 to 384.49B. NONOF holds the highest valuation in this group at 384.49B. The lowest valued company is MYMX at 151.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -1%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -3%. VSBC experienced the highest price growth at 400%, while OMGAQ experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -30% and the average quarterly volume growth was 173%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 69
SMR Rating: 92
Profit Risk Rating: 94
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
BTDR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
08 Kallang Avenue
Phone
+65 62828220
Employees
183
Web
https://www.bitdeer.com